Literature DB >> 18776119

Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis.

Shaolin Shi1, Liping Yu, Celine Chiu, Yezhou Sun, Jin Chen, Greg Khitrov, Matthias Merkenschlager, Lawrence B Holzman, Weijia Zhang, Peter Mundel, Erwin P Bottinger.   

Abstract

Dicer is an enzyme that generates microRNA (miRNA), which are small, noncoding RNA that function as important regulators of gene and protein expression. For exploration of the functional roles of miRNA in glomerular biology, Dicer was inactivated selectively in mouse podocytes. Mutant mice developed proteinuria 4 to 5 weeks after birth and died several weeks later, presumably from kidney failure. Multiple abnormalities were observed in glomeruli of mutant mice, including foot process effacement, irregular and split areas of the glomerular basement membrane, podocyte apoptosis and depletion, mesangial expansion, capillary dilation, and glomerulosclerosis. Gene profiling revealed upregulation of 190 genes in glomeruli isolated from mutant mice at the onset of proteinuria compared with control littermates. Target sequences for 16 miRNA were significantly enriched in the 3'-untranslated regions of the 190 upregulated genes. Further suggesting validity of the in silico analysis, six of the eight top-candidate miRNA were identified in miRNA libraries generated from podocyte cultures; these included four members of the mir-30 miRNA family, which are known to degrade target transcripts directly. Among 15 upregulated target genes of the mir-30 miRNA, four genes known to be expressed and/or functional in podocytes were identified, including receptor for advanced glycation end product, vimentin, heat-shock protein 20, and immediate early response 3. Receptor for advanced glycation end product and immediate early response 3 are known to mediate podocyte apoptosis, whereas vimentin and heat-shock protein-20 are involved in cytoskeletal structure. Taken together, these results provide a knowledge base for ongoing investigations to validate functional roles for the mir-30 miRNA family in podocyte homeostasis and podocytopathies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776119      PMCID: PMC2573016          DOI: 10.1681/ASN.2008030312

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  61 in total

Review 1.  Renal basement membrane components.

Authors:  J H Miner
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

2.  Maternal microRNAs are essential for mouse zygotic development.

Authors:  Fuchou Tang; Masahiro Kaneda; Dónal O'Carroll; Petra Hajkova; Sheila C Barton; Y Andrew Sun; Caroline Lee; Alexander Tarakhovsky; Kaiqin Lao; M Azim Surani
Journal:  Genes Dev       Date:  2007-03-15       Impact factor: 11.361

3.  Dicer-dependent pathways regulate chondrocyte proliferation and differentiation.

Authors:  Tatsuya Kobayashi; Jun Lu; Bradley S Cobb; Stephen J Rodda; Andrew P McMahon; Ernestina Schipani; Matthias Merkenschlager; Henry M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-31       Impact factor: 11.205

4.  Mutagenesis analysis of human SM22: characterization of actin binding.

Authors:  Y Fu; H W Liu; S M Forsythe; P Kogut; J F McConville; A J Halayko; B Camoretti-Mercado; J Solway
Journal:  J Appl Physiol (1985)       Date:  2000-11

5.  MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.

Authors:  Irena Ivanovska; Alexey S Ball; Robert L Diaz; Jill F Magnus; Miho Kibukawa; Janell M Schelter; Sumire V Kobayashi; Lee Lim; Julja Burchard; Aimee L Jackson; Peter S Linsley; Michele A Cleary
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

6.  S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.

Authors:  Estelle Leclerc; Günter Fritz; Mirjam Weibel; Claus W Heizmann; Arnaud Galichet
Journal:  J Biol Chem       Date:  2007-08-28       Impact factor: 5.157

Review 7.  The spectrum of podocytopathies: a unifying view of glomerular diseases.

Authors:  R C Wiggins
Journal:  Kidney Int       Date:  2007-04-04       Impact factor: 10.612

8.  Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure.

Authors:  Jian-Fu Chen; Elizabeth P Murchison; Ruhang Tang; Thomas E Callis; Mariko Tatsuguchi; Zhongliang Deng; Mauricio Rojas; Scott M Hammond; Michael D Schneider; Craig H Selzman; Gerhard Meissner; Cam Patterson; Gregory J Hannon; Da-Zhi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-06       Impact factor: 11.205

9.  RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis.

Authors:  Jiancheng Guo; Radha Ananthakrishnan; Wu Qu; Yan Lu; Nina Reiniger; Shan Zeng; Wanchao Ma; Rosa Rosario; Shi Fang Yan; Ravichandran Ramasamy; Vivette D'Agati; Ann Marie Schmidt
Journal:  J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 10.121

10.  Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development.

Authors:  Wigard P Kloosterman; Anne K Lagendijk; René F Ketting; Jon D Moulton; Ronald H A Plasterk
Journal:  PLoS Biol       Date:  2007-08       Impact factor: 8.029

View more
  173 in total

1.  The miR-183/ItgA3 axis is a key regulator of prosensory area during early inner ear development.

Authors:  Priscilla Van den Ackerveken; Anaïs Mounier; Aurelia Huyghe; Rosalie Sacheli; Pierre-Bernard Vanlerberghe; Marie-Laure Volvert; Laurence Delacroix; Laurent Nguyen; Brigitte Malgrange
Journal:  Cell Death Differ       Date:  2017-08-04       Impact factor: 15.828

Review 2.  MicroRNAs in kidney development: lessons from the frog.

Authors:  Oliver Wessely; Raman Agrawal; Uyen Tran
Journal:  RNA Biol       Date:  2010-05-02       Impact factor: 4.652

Review 3.  MicroRNAs in renal development.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  Pediatr Nephrol       Date:  2012-06-02       Impact factor: 3.714

4.  Managing microvascular complications of diabetes with microRNAs.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 10.121

5.  The long and short of microRNAs in the kidney.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

6.  Regulation of WNK1 expression by miR-192 and aldosterone.

Authors:  Emilie Elvira-Matelot; Xiao-ou Zhou; Nicolette Farman; Geneviève Beaurain; Alexandra Henrion-Caude; Juliette Hadchouel; Xavier Jeunemaitre
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

7.  Differential microRNA expression in the serum of patients with nephrotic syndrome and clinical correlation analysis.

Authors:  Jian Teng; Fang Sun; Peng-Fei Yu; Ji-Xia Li; Dong Yuan; Jing Chang; Shu-Hua Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 8.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

9.  Triptolide protects podocytes from TGF-β-induced injury by preventing miR-30 downregulation.

Authors:  Qianqian Yang; Mengjie Sun; Ying Chen; Yuqiu Lu; Yuting Ye; Hui Song; Xiaodong Xu; Shaolin Shi; Jinquan Wang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 10.  MicroRNAs in the pathogenesis of cystic kidney disease.

Authors:  Yu Leng Phua; Jacqueline Ho
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.